Congratulations to Dr. Eileen Kennedy, Dr. Samuel C. Benedict Professor in the department of pharmaceutical and biomedical sciences at the College of Pharmacy, who has received notice from the Michael J. Fox Foundation for Parkinson’s Research that her grant titled, “Biochemical and Structural Characterization of the LRRK2 Activation Cycle to Develop LRRK2 Inhibitors,” has been funded for $1.46 Million. Dr. Kennedy is a PI on this grant, which represents an international team including The German Center for Neurodegenerative Diseases and The University of Groningen in the Netherlands.

Eileen Kennedy awarded $1.46 million grant for her work on LRRK2 inhibitors
- College of Pharmacy 60 at 60
- Department Head of Clinical and Administrative Pharmacy Search
- Faculty and Staff Wellness Resources
- Home
- PharmCast
- Strategic Plan 2025: Our Prescription for the Future
- Student Wellness Resources
- Virtual Homecoming 2020
- Virtual Pharmtoberfest 2020
- About
- Academic Programs
- Bachelor of Science
- Master of Science
- Master of Science in Clinical & Experimental Therapeutics (MCET)
- Master of Science in Pharmaceutical Health Services, Outcomes, & Policy
- Pharmaceutical & Biomedical Sciences
- Regulatory Sciences Master’s Degree
- Toxicology (Clinical & Administrative Pharmacy)
- Toxicology (Pharmaceutical & Biomedical Sciences)
- Ph.D.
- Professional Degree (Pharm.D.)
- Certificates
- Dual Degree
- Experience Programs
- Interprofessional Education
- Residency Programs
- Departments
- Academic
- Clinical & Administrative Pharmacy
- Pharmaceutical & Biomedical Sciences
- Administrative Offices
- Academic
- Directory
- Research
- News & Events
- Students
- Alumni & Giving
- Faculty & Staff
- Giving
- Apply Now